Loading clinical trials...
Loading clinical trials...
The aim of this work is to evaluate efficacy and tolerability of preservative containing 0.0015% tafluprost and preservative-free 0.0015% tafluprost. Both preservative containing and preservative-free...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gangnam Severance Hospital
NCT07462000 · Primary Open-Angle Glaucoma (POAG), Cataract
NCT05432245 · Primary Open-angle Glaucoma, Cataract
NCT03673644 · Primary Open-angle Glaucoma
NCT07480577 · Primary Open-Angle Glaucoma (POAG)
NCT06321562 · Primary Open-angle Glaucoma
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions